"Tumour microenvironment" trang 1 - tải miễn phí từ tailieunhanh
Stem/progenitor cell marker expression in clear cell renal cell carcinoma: A potential relationship with the immune microenvironment to be explored

Stem/progenitor cell marker expression in clear cell renal cell carcinoma: A potential relationship with the immune microenvironment to be explored
10    93    0
Canine transmissible venereal tumour established in immunodefcient mice reprograms the gene expression profles associated with a favourable tumour microenvironment to enable cancer malignancy

Canine transmissible venereal tumour established in immunodefcient mice reprograms the gene expression profles associated with a favourable tumour microenvironment to enable cancer malignancy
14    24    1
The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation

The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation
13    47    1
Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): The crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC

Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): The crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC
14    46    1
Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: The role of platelet-activating factor

Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: The role of platelet-activating factor
10    78    0
Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma
16    38    1
Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma

Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma
12    79    1
Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma

Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma
16    29    1
Analysis of m7G-Related signatures in the tumour immune microenvironment and identification of clinical prognostic regulators in breast cancer

Analysis of m7G-Related signatures in the tumour immune microenvironment and identification of clinical prognostic regulators in breast cancer
21    6    1
Hyperthermia inhibits cellular function and induces immunogenic cell death in renal cell carcinoma

Hyperthermia inhibits cellular function and induces immunogenic cell death in renal cell carcinoma
7    6    1
MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers

MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers
14    56    0
The prognostic significance of tumourstroma ratio in endometrial carcinoma

The prognostic significance of tumourstroma ratio in endometrial carcinoma
8    62    1
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia

Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
17    58    1
Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: A study protocol for an open-label phase I/ II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma

Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: A study protocol for an open-label phase I/ II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma
11    24    1
Novel human lymph node-derived matrix supports the adhesion of metastatic oral carcinoma cells

Novel human lymph node-derived matrix supports the adhesion of metastatic oral carcinoma cells
12    1    1
A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer

A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer
13    1    1
Development of a luciferase/luciferin cell proliferation (XenoLuc) assay for real-time measurements of Gfp-Luc2-modified cells in a co-culture system

Development of a luciferase/luciferin cell proliferation (XenoLuc) assay for real-time measurements of Gfp-Luc2-modified cells in a co-culture system
11    68    0
In silico analysis of the immune microenvironment in bladder cancer

In silico analysis of the immune microenvironment in bladder cancer
11    88    0
Altered monocyte differentiation and macrophage polarization patterns in patients with breast cancer

Altered monocyte differentiation and macrophage polarization patterns in patients with breast cancer
9    72    1
‘DURVIT’: A phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: Safety, toxicity and effect on the primary tumour and lymph node microenvironment

‘DURVIT’: A phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: Safety, toxicity and effect on the primary tumour and lymph node microenvironment
8    71    1